Igor Legen

471 total citations
26 papers, 378 citations indexed

About

Igor Legen is a scholar working on Pharmaceutical Science, Oncology and Gastroenterology. According to data from OpenAlex, Igor Legen has authored 26 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 7 papers in Oncology and 6 papers in Gastroenterology. Recurrent topics in Igor Legen's work include Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (7 papers) and Advanced Drug Delivery Systems (7 papers). Igor Legen is often cited by papers focused on Drug Solubulity and Delivery Systems (15 papers), Drug Transport and Resistance Mechanisms (7 papers) and Advanced Drug Delivery Systems (7 papers). Igor Legen collaborates with scholars based in Slovenia, Japan and North Macedonia. Igor Legen's co-authors include Albin Kristl, Janez Kerč, Simon Žakelj, Jurij Trontelj, Saša Baumgartner, Luka Peternel, Tea Lanišnik Rižner, Raja Velagapudi, Katja Kristan and Amitava Mitra and has published in prestigious journals such as International Journal of Pharmaceutics, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Igor Legen

26 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Legen Slovenia 14 182 109 56 53 48 26 378
Isabel Lozoya-Agulló Spain 14 259 1.4× 169 1.6× 117 2.1× 39 0.7× 30 0.6× 14 509
Jens Van Den Αbeele Belgium 10 233 1.3× 53 0.5× 58 1.0× 67 1.3× 103 2.1× 10 422
Jari Rubbens Belgium 9 193 1.1× 46 0.4× 66 1.2× 45 0.8× 82 1.7× 11 397
Maria Vertzoni Greece 9 272 1.5× 74 0.7× 73 1.3× 47 0.9× 43 0.9× 11 404
Sara Carlert Sweden 6 392 2.2× 99 0.9× 78 1.4× 60 1.1× 56 1.2× 12 512
M. Oth Belgium 7 400 2.2× 181 1.7× 69 1.2× 79 1.5× 69 1.4× 7 577
Danny Riethorst Belgium 9 259 1.4× 112 1.0× 89 1.6× 35 0.7× 110 2.3× 12 447
Niklas J. Koehl Ireland 12 271 1.5× 40 0.4× 88 1.6× 37 0.7× 40 0.8× 19 461
Naoki Nagahara Japan 7 294 1.6× 82 0.8× 110 2.0× 29 0.5× 59 1.2× 9 461
Masayuki Akimoto Japan 12 169 0.9× 94 0.9× 129 2.3× 29 0.5× 29 0.6× 39 490

Countries citing papers authored by Igor Legen

Since Specialization
Citations

This map shows the geographic impact of Igor Legen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Legen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Legen more than expected).

Fields of papers citing papers by Igor Legen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Legen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Legen. The network helps show where Igor Legen may publish in the future.

Co-authorship network of co-authors of Igor Legen

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Legen. A scholar is included among the top collaborators of Igor Legen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Legen. Igor Legen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legen, Igor, et al.. (2023). Predictive Potential of Acido-Basic Properties, Solubility and Food on Bioequivalence Study Outcome: Analysis of 128 Studies. Drugs in R&D. 23(3). 211–220. 3 indexed citations
2.
Grabnar, Iztok, et al.. (2023). Predictive Potential of BCS and Pharmacokinetic Parameters on Study Outcome: Analysis of 198 In Vivo Bioequivalence Studies. European Journal of Drug Metabolism and Pharmacokinetics. 48(3). 241–255. 5 indexed citations
3.
Trontelj, Jurij, et al.. (2020). The biorelevant simulation of gastric emptying and its impact on model drug dissolution and absorption kinetics. European Journal of Pharmaceutics and Biopharmaceutics. 149. 113–120. 15 indexed citations
4.
Trontelj, Jurij, et al.. (2019). Design of an Innovative Advanced Gastric Simulator. Dissolution Technologies. 26(2). 20–29. 12 indexed citations
5.
Mitra, Amitava, et al.. (2018). Physiologically based absorption modeling to predict bioequivalence of controlled release and immediate release oral products. European Journal of Pharmaceutics and Biopharmaceutics. 134. 117–125. 20 indexed citations
6.
Trontelj, Jurij, et al.. (2016). A Novel Intestine Model Apparatus for Drug Dissolution Capable of Simulating the Peristaltic Action. AAPS PharmSciTech. 18(5). 1646–1656. 12 indexed citations
7.
Legen, Igor, Luka Peternel, Bertil Abrahamsson, et al.. (2015). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam. Journal of Pharmaceutical Sciences. 104(9). 2676–2687. 19 indexed citations
8.
Legen, Igor, et al.. (2014). Neuro-fuzzy Models as an IVIVR Tool and Their Applicability in Generic Drug Development. The AAPS Journal. 16(2). 324–334. 1 indexed citations
9.
10.
Peternel, Luka, et al.. (2012). Suitability of Isolated Rat Jejunum Model for Demonstration of Complete Absorption in Humans for BCS-Based Biowaiver Request. Journal of Pharmaceutical Sciences. 101(4). 1436–1449. 19 indexed citations
11.
Legen, Igor, et al.. (2009). Permeability of a novel β-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro. Journal of Pharmacy and Pharmacology. 61(9). 1211–1218. 8 indexed citations
12.
Legen, Igor, et al.. (2009). Permeability of a novel β-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum <I>in vitro</I>. Journal of Pharmacy and Pharmacology. 61(9). 1211–1218. 5 indexed citations
13.
Legen, Igor, et al.. (2005). The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin. International Journal of Pharmaceutics. 308(1-2). 84–89. 29 indexed citations
14.
Legen, Igor & Albin Kristl. (2004). d-Glucose Triggers Multidrug Resistance–Associated Protein (MRP)-Mediated Secretion of Fluorescein Across Rat Jejunum in Vitro. Pharmaceutical Research. 21(4). 635–640. 18 indexed citations
15.
Legen, Igor, et al.. (2004). Comparison of different intestinal epithelia as models for absorption enhancement studies. International Journal of Pharmaceutics. 291(1-2). 183–188. 40 indexed citations
16.
Žakelj, Simon, et al.. (2004). The influence of buffer composition on tissue integrity during permeability experiments “in vitro”. International Journal of Pharmaceutics. 272(1-2). 173–180. 18 indexed citations
17.
Legen, Igor, Simon Žakelj, & Albin Kristl. (2003). Polarised transport of monocarboxylic acid type drugs across rat jejunum in vitro: the effect of mucolysis and ATP-depletion. International Journal of Pharmaceutics. 256(1-2). 161–166. 25 indexed citations
18.
Legen, Igor & Albin Kristl. (2003). pH and energy dependent transport of ketoprofen across rat jejunum in vitro. European Journal of Pharmaceutics and Biopharmaceutics. 56(1). 87–94. 24 indexed citations
19.
Legen, Igor & Albin Kristl. (2002). Ketoprofen-induced intestinal permeability changes studied in side-by-side diffusion cells. Journal of Pharmacy and Pharmacology. 54(10). 1419–1422. 16 indexed citations
20.
Legen, Igor & Albin Kristl. (2001). Comparative Permeability of Some Acyclovir Derivatives Through Native Mucus and Crude Mucin Dispersions. Drug Development and Industrial Pharmacy. 27(7). 669–674. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Lozoya-Agulló Breakdown of academic impact, for papers by Jens Van Den Αbeele Breakdown of academic impact, for papers by Jari Rubbens Breakdown of academic impact, for papers by Maria Vertzoni Breakdown of academic impact, for papers by Sara Carlert Breakdown of academic impact, for papers by M. Oth Breakdown of academic impact, for papers by Danny Riethorst Breakdown of academic impact, for papers by Niklas J. Koehl Breakdown of academic impact, for papers by Naoki Nagahara Breakdown of academic impact, for papers by Masayuki Akimoto
Rankless by CCL
2026